Metastatic Breast Cancer

>

CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.

Latest News

Martha Carlson received a diagnosis of metastatic breast cancer in 2015. Read all of Martha's blogs here!
Building Supportive Communities for Patients Navigating Cancer

August 14th 2025

Living with stage 4 cancer taught me the power of community; connecting with others provides guidance, support, and hope in an often-lonely journey.

The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, review date: © stock.adobe.com.
FDA Accepts NDA for Vepdegestrant in ESR1+ Advanced Breast Cancer

August 12th 2025

A system that alerts doctors when high-risk cancer patients are admitted helped reduce hospital readmissions: © stock.adobe.com.
New System May Help Keep High-Risk Cancer Patients Out of Hospital

July 22nd 2025

Martha Carlson received a diagnosis of metastatic breast cancer in 2015. Read all of Martha's blogs here!
IV Complications and the Challenge of Being Heard

July 21st 2025

Marissa is a “GenXer” living as a “flattie” with metastatic breast cancer since March 2014. Read more of Marissa's blogs here!
Why I Don’t Call Myself a Survivor With Metastatic Breast Cancer

June 19th 2025

More News

ASCO: Early Studies Show Promise in Treating Metastatic Breast Cancer

ASCO: Early Studies Show Promise in Treating Metastatic Breast Cancer

June 5th 2014

Debu Tripathy, MD, editor-in-chief of CURE magazine, shares the latest research in metastatic breast cancer, including targeted drugs being tested in early-phase studies that appear promising, including the PARP inhibitor veliparib, the CDK4/6 inhibitor palbociclib and the anti-angiogenesis drug trametinib.

<1
...
101112131415>